BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Tsiapa I, Loudos G, Varvarigou A, Fragogeorgi E, Psimadas D, Tsotakos T, Xanthopoulos S, Mihailidis D, Bouziotis P, Nikiforidis GC, Kagadis GC. Biological evaluation of an ornithine-modified (99m)Tc-labeled RGD peptide as an angiogenesis imaging agent. Nucl Med Biol 2013;40:262-72. [PMID: 23238128 DOI: 10.1016/j.nucmedbio.2012.10.015] [Cited by in Crossref: 26] [Cited by in F6Publishing: 20] [Article Influence: 2.4] [Reference Citation Analysis]
Number Citing Articles
1 Orsini F, Bartoli F, Guidoccio F, Puta E, Erba PA, Mariani G. Novel Single-Photon-Emitting Radiopharmaceuticals for Diagnostic Applications. Nuclear Oncology 2022. [DOI: 10.1007/978-3-319-26067-9_3-2] [Reference Citation Analysis]
2 Orsini F, Bartoli F, Guidoccio F, Puta E, Erba PA, Mariani G. Novel Single-Photon-Emitting Radiopharmaceuticals for Diagnostic Applications. Nuclear Oncology 2022. [DOI: 10.1007/978-3-031-05494-5_3] [Reference Citation Analysis]
3 Orsini F, Bartoli F, Guidoccio F, Puta E, Erba PA, Mariani G. Novel Single-Photon-Emitting Radiopharmaceuticals for Diagnostic Applications. Nuclear Oncology 2022. [DOI: 10.1007/978-3-319-26067-9_3-3] [Reference Citation Analysis]
4 Qiu L, Lin Q, Si Z, Tan H, Liu G, Zhou J, Wang T, Chen Y, Huang Y, Yu T, Jin M, Cheng D, Shi H. A Pretargeted Imaging Strategy for EGFR-Positive Colorectal Carcinoma via Modulation of Tz-Radioligand Pharmacokinetics. Mol Imaging Biol 2021;23:38-51. [PMID: 32914391 DOI: 10.1007/s11307-020-01539-z] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
5 Rouchota M, Adamiano A, Iafisco M, Fragogeorgi E, Pilatis I, Doumont G, Boutry S, Catalucci D, Zacharioudaki A, Kagadis GC. Optimization of In Vivo Studies by Combining Planar Dynamic and Tomographic Imaging: Workflow Evaluation on a Superparamagnetic Nanoparticles System. Mol Imaging 2021;2021:6677847. [PMID: 33746630 DOI: 10.1155/2021/6677847] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
6 Papagiannopoulou D. 99m Tc Radiopharmaceutical Chemistry. Handbook of Radiopharmaceuticals 2020. [DOI: 10.1002/9781119500575.ch12] [Reference Citation Analysis]
7 Ramezanizadeh M, Masterifarahani A, Sadeghzadeh N, Abediankenari S, Mardanshahi A, Maleki F. 99mTc-D(RGD): molecular imaging probe for diagnosis of αvβ3-positive tumors. Nucl Med Commun 2020;41:104-9. [PMID: 31834256 DOI: 10.1097/MNM.0000000000001121] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
8 Mohammadi R, Shokri B, Shamshirian D, Zarghi A, Shahhosseini S. Synthesis and biological evaluation of RGD conjugated with Ketoprofen/Naproxen and radiolabeled with [99mTc] via N4(GGAG) for αVβ3 integrin-targeted drug delivery. Daru 2020;28:87-96. [PMID: 31845157 DOI: 10.1007/s40199-019-00318-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
9 Qiu L, Mao W, Yin H, Tan H, Cheng D, Shi H. Pretargeted Nuclear Imaging and Radioimmunotherapy Based on the Inverse Electron-Demand Diels-Alder Reaction and Key Factors in the Pretargeted Synthetic Design. Contrast Media Mol Imaging 2019;2019:9182476. [PMID: 31531006 DOI: 10.1155/2019/9182476] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
10 Şenışık AM, İçhedef Ç, Kılçar AY, Uçar E, Arı K, Parlak Y, Bilgin ES, Teksöz S. Evaluation of New 99mTc(CO)3 + Radiolabeled Glycylglycine In Vivo. Anticancer Agents Med Chem 2019;19:1382-7. [PMID: 30947676 DOI: 10.2174/1871520619666190404154723] [Reference Citation Analysis]
11 Asati S, Pandey V, Soni V. RGD Peptide as a Targeting Moiety for Theranostic Purpose: An Update Study. Int J Pept Res Ther 2019;25:49-65. [DOI: 10.1007/s10989-018-9728-3] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 5.2] [Reference Citation Analysis]
12 Rodríguez-Álvarez Y, Cabrales-Rico A, Perera-Pintado A, Prats-Capote A, Garay-Pérez HE, Reyes-Acosta O, Pérez-García E, Chico-Capote A, Santos-Savio A. In vitro and in vivo characterization of an interleukin-15 antagonist peptide by metabolic stability, 99m Tc-labeling, and biological activity assays. J Pept Sci 2018;24:e3078. [PMID: 29656472 DOI: 10.1002/psc.3078] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
13 Orsini F, Guidoccio F, Puta E, Mariani G. Novel Single-Photon-Emitting Radiopharmaceuticals for Diagnostic Applications. Nuclear Oncology 2017. [DOI: 10.1007/978-3-319-26236-9_3] [Reference Citation Analysis]
14 Zhang Z, Zhao X, Ding C, Wang J, Zhang J, Wang F. (99m)Tc-3PRGD2 SPECT/CT Imaging for Monitoring Early Response of EGFR-TKIs Therapy in Patients with Advanced-Stage Lung Adenocarcinoma. Cancer Biother Radiopharm 2016;31:238-45. [PMID: 27563805 DOI: 10.1089/cbr.2016.2052] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
15 Shi J, Wang F, Liu S. Radiolabeled cyclic RGD peptides as radiotracers for tumor imaging. Biophys Rep 2016;2:1-20. [PMID: 27819026 DOI: 10.1007/s41048-016-0021-8] [Cited by in Crossref: 51] [Cited by in F6Publishing: 53] [Article Influence: 7.3] [Reference Citation Analysis]
16 Orsini F, Guidoccio F, Puta E, Mariani G. Novel Single-Photon-Emitting Radiopharmaceuticals for Diagnostic Applications. Nuclear Oncology 2016. [DOI: 10.1007/978-3-319-26067-9_3-1] [Reference Citation Analysis]
17 Zeglis BM, Brand C, Abdel-Atti D, Carnazza KE, Cook BE, Carlin S, Reiner T, Lewis JS. Optimization of a Pretargeted Strategy for the PET Imaging of Colorectal Carcinoma via the Modulation of Radioligand Pharmacokinetics. Mol Pharm 2015;12:3575-87. [PMID: 26287993 DOI: 10.1021/acs.molpharmaceut.5b00294] [Cited by in Crossref: 74] [Cited by in F6Publishing: 78] [Article Influence: 9.3] [Reference Citation Analysis]
18 Liu S. Radiolabeled Cyclic RGD Peptide Bioconjugates as Radiotracers Targeting Multiple Integrins. Bioconjug Chem 2015;26:1413-38. [PMID: 26193072 DOI: 10.1021/acs.bioconjchem.5b00327] [Cited by in Crossref: 72] [Cited by in F6Publishing: 74] [Article Influence: 9.0] [Reference Citation Analysis]
19 Bernsen MR, Vaissier PE, Van Holen R, Booij J, Beekman FJ, de Jong M. The role of preclinical SPECT in oncological and neurological research in combination with either CT or MRI. Eur J Nucl Med Mol Imaging 2014;41 Suppl 1:S36-49. [PMID: 24895751 DOI: 10.1007/s00259-013-2685-3] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 3.0] [Reference Citation Analysis]
20 Debordeaux F, Schulz J, Savona-baron C, Hazari PP, Lervat C, Mishra AK, Ries C, Barthe N, Vergier B, Fernandez P. 99m Tc-DTPA-bis-c(RGDfK) a potential alpha(v)beta3 integrin based homobivalent radioligand for imaging neoangiogenesis in malignant glioma and melanoma. RSC Adv 2015;5:60161-71. [DOI: 10.1039/c5ra09119e] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
21 Tsiapa I, Loudos G, Fragogeorgi EA, Bouziotis P, Psimadas D, Xanthopoulos S, Paravatou-Petsotas M, Palamaris L, Varvarigou AD, Karnabatidis D, Kagadis GC. Evaluation of ανβ3-mediated tumor expression with a 99mTc-labeled ornithine-modified RGD derivative during glioblastoma growth in vivo. Cancer Biother Radiopharm 2014;29:444-50. [PMID: 25405951 DOI: 10.1089/cbr.2014.1672] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
22 Yang Y, Ji S, Liu S. Impact of multiple negative charges on blood clearance and biodistribution characteristics of 99mTc-labeled dimeric cyclic RGD peptides. Bioconjug Chem 2014;25:1720-9. [PMID: 25144854 DOI: 10.1021/bc500309r] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 1.8] [Reference Citation Analysis]
23 Tsiapa I, Efthimiadou EK, Fragogeorgi E, Loudos G, Varvarigou AD, Bouziotis P, Kordas GC, Mihailidis D, Nikiforidis GC, Xanthopoulos S, Psimadas D, Paravatou-Petsotas M, Palamaris L, Hazle JD, Kagadis GC. (99m)Tc-labeled aminosilane-coated iron oxide nanoparticles for molecular imaging of ανβ3-mediated tumor expression and feasibility for hyperthermia treatment. J Colloid Interface Sci 2014;433:163-75. [PMID: 25128864 DOI: 10.1016/j.jcis.2014.07.032] [Cited by in Crossref: 44] [Cited by in F6Publishing: 36] [Article Influence: 4.9] [Reference Citation Analysis]
24 Hong Y, Zhu H, Hu J, Lin X, Wang F, Li C, Yang Z. Synthesis and radiolabeling of 111In-core-cross linked polymeric micelle-octreotide for near-infrared fluoroscopy and single photon emission computed tomography imaging. Bioorganic & Medicinal Chemistry Letters 2014;24:2781-5. [DOI: 10.1016/j.bmcl.2014.03.050] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
25 Munley MT, Kagadis GC, McGee KP, Kirov AS, Jang S, Mutic S, Jeraj R, Xing L, Bourland JD. An introduction to molecular imaging in radiation oncology: a report by the AAPM Working Group on Molecular Imaging in Radiation Oncology (WGMIR). Med Phys 2013;40:101501. [PMID: 24089890 DOI: 10.1118/1.4819818] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
26 Pitkänen A, Ndode-ekane XE, Łukasiuk K, Wilczynski GM, Dityatev A, Walker MC, Chabrol E, Dedeurwaerdere S, Vazquez N, Powell EM. Neural ECM and epilepsy. Progress in Brain Research 2014. [DOI: 10.1016/b978-0-444-63486-3.00011-6] [Cited by in Crossref: 33] [Cited by in F6Publishing: 34] [Article Influence: 3.7] [Reference Citation Analysis]
27 Ji S, Czerwinski A, Zhou Y, Shao G, Valenzuela F, Sowiński P, Chauhan S, Pennington M, Liu S. (99m)Tc-Galacto-RGD2: a novel 99mTc-labeled cyclic RGD peptide dimer useful for tumor imaging. Mol Pharm 2013;10:3304-14. [PMID: 23875883 DOI: 10.1021/mp400085d] [Cited by in Crossref: 32] [Cited by in F6Publishing: 33] [Article Influence: 3.2] [Reference Citation Analysis]